A weekly roundup of healthcare investigations ...

As Dr. Anthony Fauci has faced public scrutiny from congressional Republicans, the D.O.J. has pursued a quieter and more ...

Inside the Trump FBI push to investigate Fauci and find evidence Covid came from a Chinese lab - Many Trump supporters ...

Long-lived bats appear to share genetic defenses against viruses, cancer, and aging. Studying how these systems overlap may ...

Vivek Ramaswamy’s campaign is airing ads featuring local Cincinnati GOP official Linda Caudill telling a very sad story about ...

Hasitha Fernando looks at the story behind Steven Soderbergh’s pandemic thriller Contagion…Over the years Hollywood has ...

Amid rising H1N1 cases and limited supplies of the preferred flu vaccine, ICMR says an available seasonal formulation may be ...

What to know about flu and COVID-19 vaccines in 2026 in preparation for the upcoming flu season.

NanoViricides announces Phase II clinical trial registration for NV-387 oral gummies to treat Ebola in the Democratic Republic of Congo amid the largest outbreak.

NanoViricides announces Phase II clinical trial for oral Ebola drug NV-387 registered in Pan African database, ready to treat patients amid growing DRC outbreak.

(NYSE American:NNVC) (the "Company"), a clinical stage leader developing antiviral drugs that viruses cannot escape, announces that its Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment ...